Exelixis (EXEL) Research & Development (2010 - 2026)

Exelixis' Research & Development history runs 17 years deep, the most recent figure standing at $199.9 million for Q2 2026.

• In Q2 2026, Research & Development fell 5.8% year-over-year to $199.9 million; the TTM figure through Apr 2026 stood at $812.7 million (down 9.19% YoY), while the FY2026 annual figure was $825.0 million, down 9.38% from the prior year.
• Research & Development for Q2 2026 stood at $199.9 million, down from $213.2 million in the prior quarter.
• The five-year high for Research & Development was $336.8 million in Q4 2022, with the low at $156.7 million in Q2 2022.
• The 5-year median for Research & Development is $213.2 million (2026), against an average of $227.7 million.
• The sharpest annual moves came in 2022 and 2024: Research & Development jumped 512.41% in 2022, then slumped 33.08% in 2024.
• Exelixis' Research & Development stood at $336.8 million in 2022, then declined by 27.36% to $244.7 million in 2023, then declined by 9.03% to $222.6 million in 2024, then fell by 10.52% to $199.2 million in 2025, then grew by 0.38% to $199.9 million in 2026.
• Business Quant data shows EXEL's Research & Development at $199.9 million in Q2 2026, $213.2 million in Q1 2026, and $199.2 million in Q4 2025.